For example, Konrade et al. [132] reported one case of a 73-year-old woman with NPHPT and osteoporosis treated with denosumab, who developed hypophosphatemia and a further increase in PTH while maintaining normal calcium levels [132]. The gene discussed is PTH; the disease is hypophosphatemia.